[go: up one dir, main page]

WO1984002704A3 - Tetracyclic compounds - Google Patents

Tetracyclic compounds

Info

Publication number
WO1984002704A3
WO1984002704A3 PCT/GB1983/000353 GB8300353W WO8402704A3 WO 1984002704 A3 WO1984002704 A3 WO 1984002704A3 GB 8300353 W GB8300353 W GB 8300353W WO 8402704 A3 WO8402704 A3 WO 8402704A3
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
substituted
alkoxy
optionally
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1983/000353
Other languages
French (fr)
Other versions
WO1984002704A2 (en
WO1984002704A1 (en
Inventor
Anthony Christopher Connell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to JP84500471A priority Critical patent/JPS60500176A/en
Priority to AU24163/84A priority patent/AU2416384A/en
Publication of WO1984002704A2 publication Critical patent/WO1984002704A2/en
Publication of WO1984002704A1 publication Critical patent/WO1984002704A1/en
Publication of WO1984002704A3 publication Critical patent/WO1984002704A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Compounds of formula (I) or a pharmaceutically acceptable salt thereof wherein: X is CH2, O, S, or NR where R is C1-4 alkyl; R1 and R2 are independently selected from hydrogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, halogen or CF3; R3 is C1-7 alkyl, C2-5 alkynyl, C3-7 cycloalkyl, C4-7 cycloalkenyl or C1-6 alkyl substituted by C2-7 alkenyl, C2-7alkynyl, C3-7 cycloalkyl, hydroxy, thiol, C1-6 alkoxy, C1-6 alkylthio, carboxy, C1-6 alkoxycarbonyl, C2-7 alkanoyl, amino optionally substituted by one or two C1-4 alkyl or by C4-6 polymethylene optionally containing an oxygen or nitrogen atom, aminocarbonyl optionally N-substituted by one or two C1-6 alkyl groups, or benzoyl or phenyl either being optionally ring-substituted by one or two C1-4 alkyl, C1-4 alkoxy, halogen or trifluoromethyl; and one of R4, R5 and R6 is C1-6 alkyl and the other two are independently hydrogen or C1-6 alkyl, having anti-depressant and/or anxiolytic activity, a process for their preparation and their use.
PCT/GB1983/000353 1982-12-30 1983-12-29 Tetracyclic compounds Ceased WO1984002704A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP84500471A JPS60500176A (en) 1982-12-30 1983-12-29 Tetracyclic compound
AU24163/84A AU2416384A (en) 1982-12-30 1983-12-29 Tetracyclic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8236881 1982-12-30

Publications (3)

Publication Number Publication Date
WO1984002704A2 WO1984002704A2 (en) 1984-07-19
WO1984002704A1 WO1984002704A1 (en) 1984-07-19
WO1984002704A3 true WO1984002704A3 (en) 1984-08-02

Family

ID=

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435042A (en) * 1965-03-30 1969-03-25 Colgate Palmolive Co Novel morphanthridine derivatives
GB1404642A (en) * 1971-10-05 1975-09-03 Akzo Nv Imidazolidine derivatives
GB1421006A (en) * 1972-03-07 1976-01-14 Akzo Nv Imidazolidine derivatives
EP0035749A1 (en) * 1980-03-08 1981-09-16 C.H. Boehringer Sohn Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
EP0073506A1 (en) * 1981-09-02 1983-03-09 Boehringer Ingelheim Kg Heterocyclic compounds, their preparation and use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435042A (en) * 1965-03-30 1969-03-25 Colgate Palmolive Co Novel morphanthridine derivatives
GB1404642A (en) * 1971-10-05 1975-09-03 Akzo Nv Imidazolidine derivatives
GB1421006A (en) * 1972-03-07 1976-01-14 Akzo Nv Imidazolidine derivatives
EP0035749A1 (en) * 1980-03-08 1981-09-16 C.H. Boehringer Sohn Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
EP0073506A1 (en) * 1981-09-02 1983-03-09 Boehringer Ingelheim Kg Heterocyclic compounds, their preparation and use

Also Published As

Publication number Publication date
EP0130202A1 (en) 1985-01-09
AU2416384A (en) 1984-08-02
JPS60500176A (en) 1985-02-07
WO1984002704A2 (en) 1984-07-19

Similar Documents

Publication Publication Date Title
AP1965A (en) Tropane derivatives useful in therapy.
NO994509L (en) Pyrrolo [2,3] pyrimidines and their use as tyrosinase inhibitors
MY106596A (en) Antifungal agents based on amides containing a phenyl group
DE3850742D1 (en) New 4-oxobenzotriazines and 4-oxoquinazolines.
FI943319A0 (en) Imidazole derivatives and their use as cytokine inhibitors
NZ506247A (en) Fungicidal 7-(alkyl, alkenyl, alkadienyl, cycloalkyl, cycloalkenyl or aryl)-[1,2,4]triazolo[1,5-a]pyrimidines
DK0770065T3 (en) Trisubstituted phenyl derivatives useful as PDE IV inhibitors
ES8800157A1 (en) Chemical compounds.
WO1999042465A3 (en) Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
ES555653A0 (en) A PROCEDURE FOR PREPARING IMIDAZOHETEROCICLICOS COMPOUNDS
EP0309422A3 (en) New amidino tricycle derivatives
ES2046671T3 (en) A PROCEDURE FOR THE PREPARATION OF TETRAHIDROIMIDAZO (1,4) BENZODIAZEPIN-2-TIONAS.
CA2118937A1 (en) Triazole Antifungal Agents
DK0919541T3 (en) New naphthalene compounds, processes for their preparation and pharmaceutical compositions containing them
CA1266675C (en)
ES8106905A1 (en) Novel benzodiazepine compounds, their preparation, intermediates employed in their preparation, and pharmaceutical compositions containing them.
ES8307244A1 (en) Azobicycloalkylbenzamides, process for their preparation and pharmaceutical compositions containing them.
KR0133073B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
ES8300762A1 (en) Azabicycloalkane derivatives, their preparation and use.
WO1984002704A3 (en) Tetracyclic compounds
GB8801491D0 (en) Novel compounds
ES2000524A6 (en) Oxa-, thia- and diazabicycloalkane derivatives, process for their preparation and their use as pharmaceuticals.
ES8401073A1 (en) Benzodiazepine compounds and their use as pharmaceuticals.
KR970009570B1 (en) Intermediates of aminobenzoic acid
BR9809313B1 (en) Vitamin D3 analog compounds, process for their preparation and use thereof for the preparation of medicaments for the treatment of primary and secondary hyperparathyroidism, renal osteodystrophy, autoimmune diseases, multiple sclerosis or lupus, and neoplastic diseases.

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): AU GB JP US

AL Designated countries for regional patents

Designated state(s): BE CH DE FR GB NL SE

AK Designated states

Designated state(s): AU GB JP US

AL Designated countries for regional patents

Designated state(s): BE CH DE FR GB NL SE

WWE Wipo information: entry into national phase

Ref document number: 1984900292

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1984900292

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1984900292

Country of ref document: EP